Company news

BioMark Diagnostics, Inc. news in 2025

BioMark Diagnostics, Inc.'s news releases, calls and decks from 2025, newest first.

View company

BioMark: 2025 Achievements & 2026 Vision

December 31, 2025

BioMark Diagnostics Announces Appointment of Mr. James Lavender to Board of Directors

December 30, 2025

BioMark Diagnostics Advances Commercialization Strategy by Initiating ISO 15189 Accreditation Program

December 23, 2025

BioMark Diagnostics Collaborative Lung Cancer Screening Project Honored by ADRIQ during the 35th Innovation Awards Gala

December 1, 2025

BioMark Aligns with National Strategy to Slash Lung Cancer Mortality with Next-Gen Liquid Biopsy

November 12, 2025

BioMark's Liquid Biopsy Platform Selected for Holistic German Lung Cancer Screening Trial

October 7, 2025

BioMark Secures Key Patents in Asia's Largest Markets for Early Lung Cancer Liquid Biopsy

September 29, 2025

BioMark Diagnostics Establishes African Market Presence Through Strategic Tunisia Healthcare Partnership

August 12, 2025

BioMark Diagnostics Announces Expansion of Its Specialty Laboratory Services in Quebec to Accommodate Increased Demand from International Partnerships

August 5, 2025

BioMark Diagnostics Highlights Fiscal Year 2025 Achievements and Sets Bold Strategic Milestones for 2025 - 2026

July 30, 2025

BioMark Diagnostics Announces Breakthrough Publication Reinforcing Leadership in AI-Powered Metabolomics for Oncology

May 20, 2025

BioMark Diagnostics Announces Landmark Publication Validating High Specificity and Accuracy of Its Early-Stage Lung Cancer Test

May 12, 2025

BioMark Diagnostics Announces Uplisting to OTCQB Venture Market

May 8, 2025

BioMark Announces the Final Closing of Oversubscribed Private Placement

March 31, 2025

BioMark Secures Financing for Initial Tranche to Advance Early-Detection Oncology Testing Platform

March 26, 2025

BioMark Diagnostics Underscores Commitment to Rare Disease Research on Rare Disease Day 2025

February 28, 2025

Decks in 2025